Glutamic Acid

Glutamic Acid

SCHEMBL161669

ClCC1CNCCc2ccccc21.N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 1/20 0.39
GRM6 O15303 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GSR P00390 1/20 0.39
CYP1A2 P05177 1/20 0.39
GRIK1 P39086 1/20 0.39
GRM5 P41594 1/20 0.39
GRIA1 P42261 1/20 0.39
GRIA2 P42262 1/20 0.39
GRIA3 P42263 1/20 0.39
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
SLC1A1 P43005 1/20 0.39
GRIA4 P48058 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIK2 Q13002 1/20 0.39
GRIK3 Q13003 1/20 0.39
GRIN2B Q13224 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutamic Acid SCHEMBL158772 1.00 GRM8 (0.39) GRM8GRM6GRIN2DGRIN3BGSR
Aspartic Acid SCHEMBL162152 0.89 TAAR1 (0.40) CYP1A2SLC1A3SLC1A2SLC1A1TAAR1
Aspartic Acid SCHEMBL162170 0.89 TAAR1 (0.40) CYP1A2SLC1A3SLC1A2SLC1A1TAAR1
Succinic Acid SCHEMBL161276 0.87 TAAR1 (0.47) TAAR1HTR2CHTR2AHTR2BTSHR
Adipic Acid SCHEMBL161399 0.85 HTR2C (0.48) TAAR1HTR2CHTR2AHTR2BTSHR
Adipic Acid SCHEMBL174687 0.85 HTR2C (0.48) TAAR1HTR2CHTR2AHTR2BTSHR
Glutamic Acid SCHEMBL174564 0.84 HTR2C (0.59) GRM8GRM6GRIN2DGRIN3BGSR
Malonic Acid SCHEMBL160930 0.82 TAAR1 (0.47) TAAR1HTR2CHTR2AHTR2BTSHR
Glycolic Acid SCHEMBL162065 0.82 TAAR1 (0.47) TAAR1HTR2CHTR2AHTR2BTSHR
Alpha-Ketoglutaric Acid SCHEMBL162746 0.82 TAAR1 (0.42) TAAR1HTR2CHTR2AHTR2BTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012030953-A1 5-HT2C RECEPTOR AGONISTS IN THE TREATMENT OF DISORDERS AMELIORATED BY REDUCTION OF NOREPINEPHRINE LEVEL ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed